ÂÜÀòÂÒÂ×

Mark Gramling is an experienced professional in the oncology sector, currently serving as Vice President at LARVOL since September 2019, where previous roles included Director of Oncology and Project and Operations Manager. Mark's expertise spans operations consulting for start-ups focused on economic modeling and market evaluation, as well as leading healthcare services coordination at Everett Castle Health. Prior roles at inVentiv Health Consulting and HealthHelp involved program management and client engagement strategies in pharmaceutical outcomes research. Academic credentials include a PhD in Pathology from the University of North Carolina at Chapel Hill and a BSc in Biochemistry from Clemson University, complemented by research experience at Vanderbilt University Medical Center and UNC, focusing on oncology and cellular signaling.